Search Results - "Jacques Zoungrana"
-
1
Hyperimmune malarial splenomegaly in a malaria-endemic area of southwest Burkina Faso: case of Bobo-Dioulasso
Published in BMC infectious diseases (13-08-2024)“…Hyperreactive malarial splenomegaly (HMS) is one of the main causes of massive splenomegaly in malaria-endemic zones. Diagnosis is often challenging in…”
Get full text
Journal Article -
2
Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country
Published in PloS one (14-06-2023)“…This study aimed to evaluate the seroprevalence of anti-SARS-CoV-2 IgG and factors associated with the infection among PLWHIV over the first 12 months…”
Get full text
Journal Article -
3
Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso
Published in BMC infectious diseases (22-02-2023)“…An issue of particular concern is the impact of the 2019 novel coronavirus (2019 nCOV) on the people coinfected with the Human Immuno-deficiency Virus (HIV)…”
Get full text
Journal Article -
4
Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): Findings from hospital based cross-sectional study
Published in International journal of infectious diseases (01-07-2021)“…COVID-19 is one of the world’s major health crises. The objective of this study was to determine the predictive factors of severe hypoxemia in patients…”
Get full text
Journal Article -
5
Comparing antibiotic susceptibility profiles of urinary tract infection isolates in a University Hospital in Burkina Faso: Community vs. hospital profiles
Published in Microbes and Infectious Diseases (01-02-2024)“…Background: The emergence of antimicrobial resistance (AMR) within bacterial pathogens necessitates a local comprehension of the epidemiological context. This…”
Get full text
Journal Article -
6
Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting
Published in BMC nephrology (07-05-2019)“…It has been reported that people living with HIV in West Africa exhibited the highest risks for chronic kidney disease (CKD) in the world. Here, we aimed at…”
Get full text
Journal Article -
7
Dengue infection during pregnancy in Burkina Faso: a cross-sectional study
Published in BMC infectious diseases (27-11-2019)“…Dengue fever is prevalent in the world; in recent years, several outbreaks occurred in West Africa. It affects pregnant women. We aimed to assess the…”
Get full text
Journal Article -
8
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
Published in International journal of infectious diseases (01-05-2022)“…•Hydroxychloroquine + azithromycin (HCQ + AZ) did not reduce recovery time in COVID-19•HCQ + AZ had no effect on the risk of worsening or transfer to the…”
Get full text
Journal Article -
9
Prevalence of human leukocyte antigen HLA-B57:01 in individuals with HIV in West and Central Africa
Published in BMC immunology (22-07-2021)“…The presence of the human leukocyte antigen HLA-B*57:01 is associated with the development of a hypersensitivity reaction to abacavir (ABC). Limited data exist…”
Get full text
Journal Article -
10
TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study
Published in PloS one (08-11-2017)“…Bone demineralization, which leads to osteoporosis and increased fracture risk, is a common metabolic disorder in HIV-infected individuals. In this study, we…”
Get full text
Journal Article -
11
Future of HIV2 and HIV2 + 1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015
Published in Journal of the International Association of Providers of AIDS Care (01-01-2022)“…Introduction: HIV2 is endemic in West Africa. In Burkina Faso, its prevalence was estimated at 2%. The aim of this work was to evaluate the follow-up of…”
Get full text
Journal Article -
12
APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa
Published in Kidney international reports (01-03-2022)“…APOL1 G1 and G2 alleles have been associated with kidney-related outcomes in people living with HIV (PLHIV) of Black African origin. No APOL1-related kidney…”
Get full text
Journal Article -
13
Detection and molecular characterization of multiresistant Enterobacteriaceae carried by houseflies in the city of Bobo-Dioulasso, Burkina Faso
Published in International journal of one health (01-01-2024)“…Background and Aim: Houseflies (Musca domestica) are synanthropic insects that are vectors of a wide range of multidrug-resistant pathogens responsible for…”
Get full text
Journal Article -
14
Fréquence élevée de l´ischémie myocardique asymptomatique dans une population de patients infectés par le VIH à Bobo-Dioulasso, Burkina Faso
Published in The Pan African medical journal (16-02-2021)“…Introductionles complications cardiovasculaires sont devenues la 3e cause de décès et le 4e motif d´hospitalisation des patients infectés par le VIH…”
Get full text
Journal Article -
15
Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study
Published in The Pan African medical journal (2016)“…In Sub-Saharan Africa, few studies reported pregnancy incidence and outcomes in women taking antiretroviral therapy (ART). This survey aims to estimate the…”
Get full text
Journal Article -
16
Description d’un nouveau foyer épidémique de leishmaniose cutanée à Leishmania major à l’Ouest du Burkina Faso
Published in The Pan African medical journal (01-01-2020)“…Introductionau Burkina Faso, le seul foyer de leishmaniose cutanée (LC) avec confirmation biologique dans la littérature à notre connaissance est celui de…”
Get full text
Journal Article -
17
-
18
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
Published in The lancet HIV (01-06-2024)“…Due to the low number of individuals with HIV-2, no randomised trials of HIV-2 treatment have ever been done. We hypothesised that a non-comparative study…”
Get full text
Journal Article -
19
Genotypic resistance profiles of HIV-2-treated patients in West Africa
Published in AIDS (London) (15-05-2014)“…To assess the virological response, genotypic resistance profiles, and antiretroviral plasma concentrations in HIV-2 antiretroviral-treated (antiretroviral…”
Get full text
Journal Article -
20
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
Published in The lancet HIV (01-09-2017)“…Summary Background Despite satisfactory efficacy of WHO-recommended second-line antiretroviral treatment for patients with HIV in low-income countries, the…”
Get full text
Journal Article